C. Pomari

发表

Famotidine and Theophylline Pharmacokinetics

R. Negro, C. Pomari, P. Turco, 1993, Clinical pharmacokinetics.

Salmeterol & Fluticasone 50 μg/250 μg bid in combination provides a better long-term control than salmeterol 50 μg bid alone and placebo in COPD patients already treated with theophylline

R. Negro, C. Micheletto, C. Pomari, 2003 .

Prevalence and features of asthma–chronic obstructive pulmonary disease overlap in Northern Italy general population

G. Viegi, M. Caminati, C. Pomari, 2019, The Journal of asthma : official journal of the Association for the Care of Asthma.

PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability

G. Rossi, G. Netto, G. Zamboni, 2017, Oncotarget.

Once-Daily Nebivolol 5mg Does Not Reduce Airway Patency in Patients with Chronic Obstructive Pulmonary Disease and Arterial Hypertension

R. D. Dal Negro, C. Pomari, S. Tognella, 2002 .

An Ovine Model of GERD-Induced Bronchoconstriction

R. Negro, L. Allegra, W. Abraham, 1999 .

Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA‐sensitive asthmatics: a controlled study vs placebo

M. Visconti, C. Micheletto, R. D. Dal Negro, 2004, Allergy.

Blood Gas Changes Induced by Ultrasonically Nebulized Distilled Water Are Reduced by Inhaled Furosemide

R. Negro, L. Allegra, A. Cogo, 1995 .

Prevalence of SARS-CoV-2, Verona, Italy, April–May 2020

Z. Bisoffi, C. Micheletto, A. Poli, 2020, Emerging infectious diseases.

Salmeterol & fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophylline.

C. Micheletto, R. D. Dal Negro, C. Pomari, 2003, Pulmonary pharmacology & therapeutics.

Clinical Use of Controlled-Release Theophylline in Chronic Airways Obstruction

R. D. Dal Negro, C. Pomari, P. Turco, 1987, The Journal of international medical research.

Genetic Predisposition in Asthma

C. Pomari, P. Turco, 1993 .

Indwelling Pleural Catheters: A Clinical Option in Trapped Lung.

S. Paiano, C. Pomari, L. Bertolaccini, 2017, Thoracic surgery clinics.

Lung Function and Bronchial Hyperreactivity

R. Negro, C. Pomari, 1999 .

Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol

Z. Bisoffi, C. Micheletto, A. Poli, 2020, BMJ Open.

G. Zamboni, S. Paiano, C. Pomari, 2018, Interactive cardiovascular and thoracic surgery.

COPD prevalence in a north-eastern Italian general population.

Giovanni Viegi, Giancarlo Cesana, Marco Caminati, 2015, Respiratory medicine.

Omalizumab management beyond clinical trials: the added value of a network model.

M. Caminati, A. Vianello, A. Rossi, 2014, Pulmonary pharmacology & therapeutics.

Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.

R. D. Dal Negro, C. Pomari, P. Turco, 1986, International journal of clinical pharmacology research.

Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

C. Piubelli, M. Deiana, Z. Bisoffi, 2023, Emerging infectious diseases.

Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.

E. Kerwin, H. Watz, F. Maltais, 2022, The Lancet. Respiratory medicine.

Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.

R. D. Dal Negro, C. Pomari, P. Turco, 1984, International journal of clinical pharmacology, therapy, and toxicology.

Calcitonin nasal spray in patients with chronic asthma: a double-blind crossover study vs placebo.

R. D. Dal Negro, C. Pomari, P. Turco, 1991, International journal of clinical pharmacology, therapy, and toxicology.

Ambulatory Esophageal pH Monitoring in the Diagnosis of Gastroesophageal Reflux

M. Dinelli, C. Pomari, D. Fossati, 1999 .

Prevention of bronchial hyperreactivity in atopic asthmatics during the period of maximal allergenic risk: a six-month study.

R. D. Dal Negro, C. Pomari, P. Turco, 1986, International journal of clinical pharmacology, therapy and toxicology.

Bronchial reacutization and gastroesophageal reflux: is there a potential clinical correlation?

S. Paiano, C. Pomari, L. Bertolaccini, 2016, Annals of Translational Medicine.

Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.

C. Micheletto, C. Pomari, P. Turco, 1999, Journal of investigational allergology & clinical immunology.

Combined administration of controlled release theophylline and ranitidine: a 53‐day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.

C. Pomari, P. Turco, F. de Conti, 1987, The British journal of clinical practice.

Fiberoptic bronchoscopy for the detection of the gastric pepsin (Pep-test)

S. Paiano, C. Pomari, L. Bertolaccini, 2016 .